近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1.Lei Gong, Yuhua Wei, Xin Yu, Jirun Peng, and Xisheng Leng. 3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells: in vitro and in vivo Findings. Anti-Cancer Agents in Medicinal Chemistry, 2014 ;14(5):771-776.
2.Zhuqingqing Cui, Xin Yu, Limin Guo, Yuhua Wei, Shengmin Zheng, Wenxia Li, Pengcheng Chen, Jiye Zhu, Jirun Peng. Combined Analysis of Serum Alpha-Fetoprotein and MAGE-A3-Specific Cytotoxic T Lymphocytes in Peripheral Blood for Diagnosis of Hepatocellular Carcinoma. Disease Markers, 2013; 35(6):915–923.
3.朱卫华，张大方，郑晟旻，金仲田，甘丽云，李澍，冷希圣，彭吉润。微波消融治疗24例结直肠癌肝转移的临床疗效分析。腹部外科，2013;26(2)：19-22。
4.PENG-CHENG CHEN, JI-RUN PENG, LEI HUANG, WEN-XIA LI, WEN-ZHEN WANG, ZHU-QING-QING CUI, HUI HAN, LEI GONG, DA-PENG XIANG, SHI-SHI QIAO, XIN YU, YU-HUA WEI, LI-PING MA, NA LI, JI-YE ZHU and XI-SHENG LENG. Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro. ONCOLOGY REPORTS, 2013, 30: 1157-1164.
5.丁磊，高宏，陈奕至，黄静，朱煜冰，孔璐，昌红，彭吉润。Claudin-7基因敲除诱导小鼠肠道炎症及其致癌机制的研究。中华普通外科杂志，2013;28(2)：120-124。
6.Peng Jirun, Guoxin Zhang, Seon-Ah Ha, Hyun Kee Kim, Jinah Yoo, Sanghee Kim, Jin Zhongtian, Cui Zhuqingqing, Youn Soo Lee,Gi Hwan Gong, Joo Hee Yoon, Hae Nam Lee,Sa Jin Kim, Tae Eung Kim, Eun Young Song, Yun Kyung Lee, Yong Gyu Park, Jin Woo Kim. HCCR-1 for detecting small hepatocellular carcinoma latent in a cirrhotic liver: a prospective cohort study. Gut, 2012; 61(10):1514-1515.
7.Lei Gong, Zhuqingqing Cui, Pengcheng Chen, Hui Han, Jirun Peng, Xisheng Leng. Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II. Med Oncol; 2012; 29(2): 909-914.
8.Lei Gong, Zhuqingqing Cui, Xin Yu, Yuhua Wei,Jirun Peng, Xisheng Leng.Hexokinase II in CD133+ and CD133- hepatoma BEL-7402 Cells. Pathol Oncol Res, 2012; 18(2): 377-381.
9.W Wen, L Zhang, J Peng, J Chen, J Hao, X Li, X Qian, P Zeng, Y Zhang, and Y Yin. Identification of promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the cancer-testis antigen HCA587. Cancer Sci, 2011; 102(8): 1455-1461.
10.解宝江，郑晟旻，彭吉润。消化道恶性肿瘤患者外周血25-羟基维生素D测定的临床意义。河北医药，2011;33(24)：3711-3712。
11.Peng Jirun, Guoxin Zhang, Hyun Kee Kim, Seon-Ah Ha, Jin Zhongtian, Qiao Shishi, Cui Zhuqingqing, Gong Lei, Jinah Yoo, Sanghee Kim, Yong Gyu Park, Jing Wang, Yang Yang, Zekuan Xu, Zuhu Huang, Yun Kyung Lee, Eun Young Song, Jin Woo Kim. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Disease Markers, 2011; 30(6): 307–315.
12.Shi-Shi Qiao, Zhu-Qing-Qing Cui, Lei Gong, Hui Han, Peng-Cheng Chen, Li-Min Guo, Xin Yu, Yu-Hua Wei, Seon-Ah Ha, Jin Woo Kim, Zhong-Tian Jin, Shu Li, Ji-Run Peng, Xi-Sheng Leng. Simultaneous Measurements of Serum AFP, GPC-3 and HCCR for Diagnosing Hepatocellular Carcinoma. Hepato-Gastroenterology, 2011; 58:1-6.
13.Hui Han, Ji-Run Peng, Peng-Cheng Chen, Lei Gong, Shi-Shi Qiao, Wen-Zhen Wang, Zhu-Qingqing Cui, Xin Yu, Yu-Hua Wei, Xi-Sheng Leng. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro. Biochem Biophys Res Commun, 2011; 411(3): 530-535.
14.王卉，于鑫，彭吉润，童春荣，武平，李燕燕，康蕊，孙慧鹏。流式细胞术在非造血系统肿瘤骨髓侵犯检测中的价值。中华检验医学杂志，2011;34(2)：141-146。
15.Chen L, Ho DW, Lee NP, Sun S, Lam B, Wong KF, Yi X, Lau GK, Ng EW, Poon TC, Lai PB, Cai Z, Peng J,Leng X, Poon RT, Luk JM. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker. Ann Surg Oncol, 2010; 17(9): 2518-2525.
16.L Zhao, DC Mou, JR Peng, L Huang, ZA Wu, XS Leng. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients. World J Gastroenterol, 2010; 16(32): 4072-4078.
17.Lee NP, Chen L, Lin MC, Tsang FH, Yeung C, Peng J, Leng X, Beretta L, Sun S, Day PJ, Luk JM. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J Proteome Res 2009; 8(3): 1293-1303.
18.金仲田，彭吉润，朱卫华，张大方，甘丽云，李澍，王福顺，朱继业，冷希圣。超声引导经皮微波消融治疗肝转移癌的临床疗效分析。中国普通外科基础与临床杂志，2010;17(3)：229-232。
19.Yan-Li Pang, Hua-Gang Zhang, Ji-Run Peng, Xue-Wen Pang, Shu Yu, Qiao Xing, Xin Yu, Lei Gong, Yan-Hui Yin, Yu Zhang, Wei-Feng Chen. The immunosuppressive tumor microenvironment in hepatocellular carcinoma.Cancer Immunology, Immunotherapy, 2009; 58(6): 877-886.
20.彭吉润，朱卫华，张大方，公磊，甘丽云，李澍，金仲田，王福顺，陈雷，朱继业，冷希圣。微波消融结合TACE治疗原发性肝癌疗效分析。中华普通外科杂志，2009;24(11)：885-888。
京公网安备 11010802027423号